SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-000843
Filing Date
2019-01-17
Accepted
2019-01-17 16:05:15
Documents
6
Period of Report
2019-01-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k011719_therapixbio.htm 6-K 19270
2 NOTICE OF MEETING, PROXY STATEMENT AND PROXY CARD FOR THE ANNUAL GENERAL MEETING f6k011719ex99-1_therapix.htm EX-99.1 88825
3 VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES. f6k011719ex99-2_therapix.htm EX-99.2 996
4 GRAPHIC ex99-1_001.jpg GRAPHIC 12546
5 GRAPHIC proxy1.jpg GRAPHIC 177317
6 GRAPHIC proxy2.jpg GRAPHIC 169652
  Complete submission text file 0001213900-19-000843.txt   604577
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 19531031
SIC: 2834 Pharmaceutical Preparations